Resolution Therapeutics
Resolution Therapeutics is a clinical-stage biotech developing regenerative macrophage therapies for liver disease, with $79M in funding and 82 employees. It spun out of the University of Edinburgh in 2020 and is backed by Syncona.
The growth story
Resolution Therapeutics grew from 18 to 82 employees between 2021 and 2026, raising $79M along the way, most recently a Series B in October 2024.
About
The company focuses on macrophage cell therapies for end-stage liver disease, a growing chronic condition with no current treatments beyond transplants. Its approach targets advanced cirrhosis, where demand outpaces donor organ availability.
Resolution raised $79M in a 2024 Series B, indicating strong investor interest in its academic spinout technology. With 82 staff, it draws heavily from UK pharma and academic hubs, though median tenure is just 2 years suggesting rapid team evolution.
Founders and leadership
Research dominates the org chart with 16 staff, reflecting the company's academic roots. Leadership likely combines University of Edinburgh's regenerative medicine expertise with industry veterans from top investors like Syncona.
The Resolution Therapeutics org chart
Amir Hefni (Chief Executive Officer) leads 36 mapped leaders with 11 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 28 (+27% YoY), Business Development 13 (+8% YoY), Operations 8 (-20% YoY), Information Technology 5 (+25% YoY), Finance 4 (+100% YoY), Legal 3 (+50% YoY).
Talent flow
Employees come primarily from GSK (8), University of Edinburgh (6), and Imperial College London (6), showing strong UK pharma and academic pipelines. Alumni scatter thinly across biotechs like MiAlgae and Adcendo, with no dominant destination yet.
Most common previous employers of Resolution Therapeutics staff: GSK (8), The University of Edinburgh (6), Imperial College London (6), Novartis (4), UCL (4), Achilles Therapeutics (4). Former Resolution Therapeutics employees most often moved to MiAlgae (2), LGC (1), Adcendo (1), MeiraGTx (1), ClinProtocol Management (1), Jefferies (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Resolution Therapeutics: Cell Culture (31), Molecular Biology (30), Biotechnology (30), Flow Cytometry (26), Cell Biology (26), Research Skills (25), Data Analysis (25), Life Sciences (25).
Where the team actually sits
Resolution Therapeutics people are concentrated in England, United Kingdom (25), Scotland, United Kingdom (13), United Kingdom (7), London Area, United Kingdom (6).
Search footprint
Resolution Therapeutics attracts about 44 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 10 ranking keywords and lost 2 in the last period.
What employees say
- Compensation
- 4.20 / 5
- Career opportunities
- 4.00 / 5
- Senior management
- 4.00 / 5
- Work-life balance
- 4.30 / 5
Frequently asked
Resolution Therapeutics has 82 employees as of September 2026.
Resolution Therapeutics has raised $79M in total, most recently a Series B round in October 2024.
Amir Hefni (Chief Executive Officer) sits at the top of Resolution Therapeutics's reporting structure, with 11 direct reports.
The most common previous employers of current Resolution Therapeutics staff are GSK (8 people), The University of Edinburgh (6 people), Imperial College London (6 people).
Former Resolution Therapeutics employees most often move to MiAlgae (2), LGC (1), Adcendo (1).
Resolution Therapeutics attracts about 44 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Resolution Therapeutics staff are Cell Culture, Molecular Biology, Biotechnology, Flow Cytometry, Cell Biology.
Resolution Therapeutics staff are concentrated in England, United Kingdom (25), Scotland, United Kingdom (13), United Kingdom (7).
Resolution Therapeutics has about 28 people in Research, up 27% over the past year, as of September 2026.
Resolution Therapeutics has about 13 people in Business Development, up 8% over the past year, as of September 2026.
Computed from 67 current and 53 former Resolution Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.